CIK 0001000694
- Large accelerated filer
NOVAVAX INC
Sign in to watch- Ticker
- NVAX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 222816046
- Phone
- +1 240-268-2000
- Business address
- 21 FIRSTFIELD RD, GAITHERSBURG, MD
- DEFA14A Proxy Proxy Materials
- DEFA14A Proxy Proxy Materials
- DEFA14A Proxy Proxy Materials
- NT 10-Q Other NT 10-Q
- S-8 Other Securities Offered to Employees in Benefit Plans
- DEFA14A Proxy Proxy Materials
- DEFA14A Proxy Proxy Materials
- S-3ASR Offering Registration Statement
- EFFECT Other Notice of Effectiveness
- S-8 Other Securities Offered to Employees in Benefit Plans
- DEFA14A Proxy Proxy Materials
- CT ORDER Other Confidential Order
- S-8 Other Securities Offered to Employees in Benefit Plans
- CT ORDER Other Confidential Order
- DEFA14A Proxy Proxy Materials
- EFFECT Other Notice of Effectiveness
- S-8 Other Securities Offered to Employees in Benefit Plans
- DEFA14A Proxy Proxy Materials
- EFFECT Other Notice of Effectiveness
- S-8 Other Securities Offered to Employees in Benefit Plans
Page 3 of 6 · 120 filings